Trialstat Appoints Deidre Redmond to Vice President Clinical Affairs

Ottawa, ON (PRWEB) September 22, 2006

TrialStat Corporation (, a clinical data management on demand company, today named Deidre Redmond to the position of Vice President Clinical Affairs. Ms. Redmond has more than 20 years of clinical research experience in addition to a number of years as a registered nurse in the areas of critical care and oncology. Her primary role at TrialStat will be to guide the development of ClincialAnalytics (CA) 3.0(tm), the company’s on demand EDC platform, and data management services to ensure they remain innovative, effective and standards compliant.

“Deidre’s comprehensive knowledge and breadth of clinical research experience will enhance TrialStat’s ongoing focus on delivering highly effective clinical data management solutions for our customers,” said Jonathan Barker, President and CEO, TrialStat. “Deidre has a customer perspective on EDC and data management that will be invaluable as we continue rapid expansion in our U.S. and European markets.”

Prior to joining TrialStat, Ms. Redmond managed Canscot Clinical Research, an independent consultancy specializing in clinical trial management services for pharmaceutical and biotechnology companies and contract research organizations. Her extensive clinical research experience encompasses the full clinical trial lifecycle, from study start-up to regulatory submission. This expertise also includes project management, site training, quality assurance and compliance audits, clinical study rescue and FDA audit preparation and resolution.

“Clinical research organizations are looking for new approaches to cost-effectively streamline the collection and management of trial data in order to reduce time-to-market for new drugs and treatments,” said Ms. Redmond. “TrialStat’s ability to integrate its ClinicalAnalytics EDC platform with its data management services offers research organizations an optimal on demand solution that lowers costs, speeds clinical trial implementation and enhances the quality of research.”

ClinicalAnalytics (CA) is an integrated web and handheld-based EDC solution that enables users to design, configure and manage clinical research projects themselves through a browser interface. This secure, cost-effective approach accelerates project startup, site addition and management, recruitment monitoring, query resolution and final data analysis. TrialStat’s Data Management Services group offers a spectrum of data management services, from biostatistics, data entry, adverse event coding and training to project management among others. These services are available either á la carte or in an integrated suite.


Headquartered in Ottawa, Canada, TrialStat is a privately held company that delivers clinical data management on demand by combining its full suite of data management services with the company’s software as a service products. CA 3.0 is a robust and scaleable clinical EDC on demand solution used by leading academic and contract research organizations. SRS 3.0(tm) automates systematic reviews using real-time collaboration and management tools to achieve transparent, auditable and reproducible results quickly and cost-effectively. For more information, please visit us at

ClinicalAnalytics 3.0 is a registered trademark of TrialStat Corporation.

SRS 3.0 is a registered trademark of TrialStat Corporation.

For media inquiries, please contact:

Shelley Mullins    

Media Relations, TrialStat    


Kathryn Schwab

Media Relations, TrialStat




Vocus©Copyright 1997-

, Vocus PRW Holdings, LLC.
Vocus, PRWeb, and Publicity Wire are trademarks or registered trademarks of Vocus, Inc. or Vocus PRW Holdings, LLC.

Leave a Reply

Your email address will not be published. Required fields are marked *



Lorem Ipsum has been the industrys standard dummy text ever since the 1500s, when an unknown prmontserrat took a galley of type and scrambled it to make a type specimen book.

Lorem Ipsum has been the industrys standard dummy text ever since the 1500s, when an unknown prmontserrat took a galley of type and scrambled it to make a type specimen book. It has survived not only five centuries, but also the leap into electronic typesetting, remaining essentially unchanged.